IPO vs. Direct Listing vs. SPAC: Key Differences

Equicurious Teamintermediate2025-12-13Updated: 2026-03-22
Illustration for: IPO vs. Direct Listing vs. SPAC: Key Differences. Compare the three paths to public markets with cost structures, dilution impacts...

Going public costs more than most investors realize--and the path a company chooses to get there tells you exactly who's getting the best deal. Traditional IPOs systematically underprice shares by an average of 16-20% on Day 1, transferring billions from issuing companies to underwriters' favored clients. SPACs looked like the democratic alternative--until the 2021 class destroyed hundreds of billions in value, with more than 90% of de-SPAC companies still trading below their $10 IPO price years later. The practical antidote isn't avoiding newly public companies. It's understanding who profits from each structure so you can position yourself on the right side of the trade.

How Each Path Actually Works (The Mechanics That Matter)

Three structures dominate the route from private to public, and each creates a fundamentally different set of winners and losers.

Traditional IPO: A company sells newly issued shares through investment bank underwriters. The company gets cash; underwriters collect 5-7% fees (on a $1 billion raise, that's $50-70 million just in underwriting). Underwriters also control allocation--meaning they decide which institutional clients get shares at the IPO price, before retail investors can touch them.

Direct Listing: Existing shareholders sell their shares directly on the exchange. No new shares are issued (unless the company opts for a hybrid structure, allowed since 2020). No underwriter intermediation. No lock-up period. Total advisory fees run 1-2% of valuation--roughly 80-90% cheaper than an IPO.

SPAC Merger: A publicly traded shell company (the SPAC) merges with a private target. The target becomes public through the back door. The catch: SPAC sponsors receive a 20% "promote"--essentially free shares worth hundreds of millions--regardless of whether the deal performs. Add in underwriting fees, deferred compensation, and PIPE placement costs, and effective all-in costs reach 7-8% of deal value.

What the data confirms: the structure a company chooses reveals its priorities. IPOs prioritize capital raising and institutional distribution. Direct listings prioritize cost efficiency and insider liquidity. SPACs prioritize speed and valuation certainty--at a steep price.

The Real Cost Comparison (Why Structure Is Strategy)

Numbers clarify what marketing obscures. Here's what each path actually costs:

Cost ComponentTraditional IPODirect ListingSPAC Merger
Underwriting/Advisory5-7% of proceeds0.3% of valuation5.5% + 2% deferred
Sponsor promoteNoneNone~5% (20% of founder shares)
Legal/Accounting~$5M~$6M~$20M
Total effective cost6-7%~0.4%7-8%

Example: On a $3 billion transaction, the cost gap is staggering. A traditional IPO costs roughly $195 million. A direct listing costs approximately $12 million. A SPAC merger costs around $225 million--the most expensive path by far.

The point is: Spotify saved an estimated $100 million by choosing a direct listing over an IPO in 2018. That's not a rounding error--it's real money that stayed with the company and its existing shareholders rather than flowing to Wall Street intermediaries.

The IPO Underpricing Problem (Who Really Benefits)

Here's the part that should bother you. When a company IPOs and the stock jumps 20% on Day 1, the financial media celebrates. But that "pop" represents money the issuing company left on the table.

Jay Ritter's research at the University of Florida (the most comprehensive IPO database available) shows average first-day returns of 16.3% from 1980 through 2023. During the internet bubble, that figure spiked to 65%. Even in the more disciplined 2024-2025 market--where US IPO proceeds reached $47.4 billion across 216 deals in 2025 (up from $33 billion in 2024)--underpricing persists as a structural feature, not a bug.

Why? Because underwriters have a conflict of interest (one the industry would rather you not think about). They're paid by the issuing company to sell shares, but they allocate those shares to their best institutional clients. Underpricing ensures those clients get a reliable first-day profit--which keeps them coming back. The issuer absorbs the cost.

Your calculation: If you're buying a traditional IPO at the opening price (not the IPO price), you're buying after the institutions have already captured most of the Day 1 gain. The average retail investor enters after the wealth transfer has occurred.

Why this matters: understanding this dynamic changes how you evaluate IPO investments. That 20% pop isn't "leaving money on the table for you"--it's the underwriter's gift to institutional clients, already priced in by the time you can buy.

Direct Listings: The Cost-Efficient Alternative (With Real Tradeoffs)

Direct listings eliminate underpricing by removing the underwriter from price-setting entirely. Instead, the exchange runs an opening auction where supply and demand determine the first trade price. The result is more honest price discovery--but also more volatility.

Spotify (April 2018): Reference price $132, opened at $165.90 (25.7% above reference), closed at $149.01. The company had $1.5 billion in cash and needed no capital--it just wanted to give existing shareholders liquidity without dilution. By 2024, Spotify reported its first full year of profitability, with 675 million monthly active users and revenue of EUR 4.2 billion. The direct listing worked precisely because Spotify had the brand recognition to drive price discovery without underwriter hand-holding.

Coinbase (April 2021): Reference price $250, opened at $381 (52.4% above), closed at $328.28. Day 1 volume hit 73 million shares ($25 billion traded). But without underwriter stabilization, the stock swung in a $310-$429 range on Day 1 alone. The lack of lock-up meant $1.9 billion in insider sales within the first month.

The pattern across all direct listings: Only 18 companies total used the direct listing structure from 2018 through 2024. Only a couple saw significant positive first-day returns, and most experienced substantial volatility. The roster includes Spotify, Slack, Palantir, Asana, Coinbase, and Roblox--all companies with strong consumer or developer brands. Direct listings work brilliantly for well-known companies with no capital needs (and patient shareholders who can tolerate price swings). For everyone else, the lack of institutional distribution and analyst coverage creates real challenges. Slack, for instance, opened at $38.50 against a $26 reference price but drifted lower over the following year before Salesforce acquired it--illustrating that a strong opening doesn't guarantee strong performance.

The practical takeaway: if you're evaluating a direct listing, the company's brand strength matters more than in any other structure. Without underwriters generating demand, the company's reputation is doing the heavy lifting for price discovery.

The SPAC Reckoning (What 2021's Excesses Actually Cost)

No discussion of going-public structures is complete without the cautionary tale of the 2021 SPAC boom--and the painful hangover that followed.

The boom: In 2021, SPACs accounted for 59% of US IPO capital raised ($162 billion via 613 deals). The pitch was compelling: faster execution, valuation certainty (pre-negotiated with the SPAC sponsor), and the ability to include forward-looking projections that traditional IPOs couldn't. Companies that might have waited years for an IPO window went public in months.

The bust: The numbers are brutal. De-SPAC companies (companies that went public via SPAC) underperformed traditional IPOs by 49 percentage points in the two years following their mergers. More than 90% of de-SPAC companies were still trading below their original $10 SPAC price years later. Cumulative value destruction reached into the hundreds of billions.

Redemption rates tell the real story. By 2023-2024, investors were redeeming 90-95% of trust capital before deals closed. In March 2023, the average redemption rate hit 95%. Translation: investors who could exit before the merger did--leaving the remaining shareholders holding a much smaller (and often much worse) deal.

The point is: the SPAC structure's core flaw is the sponsor promote. When sponsors receive 20% of founder shares regardless of deal quality, the incentive is to complete any merger, not the best merger. This misalignment produced exactly the outcomes you'd predict--inflated valuations, weak targets, and massive post-merger losses. Stanford research found that 2020-2021 SPACs traded at an average 47% premium to their subsequent fair values--meaning investors systematically overpaid at the merger stage, and sponsors had no reason to correct them.

The SEC Response (New Rules That Changed the Game)

Regulators noticed. On January 24, 2024, the SEC adopted sweeping new rules for SPACs, effective July 1, 2024:

  • Enhanced conflict disclosures: SPACs must now detail sponsor compensation, dilution mechanics, and conflicts of interest in plain language
  • Projection safe harbor eliminated: The Private Securities Litigation Reform Act's safe harbor for forward-looking statements is no longer available for SPACs--meaning those rosy revenue projections that fueled the 2021 boom now carry real liability
  • De-SPAC treated as securities sale: Business combinations involving shell companies are now deemed sales of securities, increasing legal accountability
  • Inline XBRL tagging required (effective June 2025) for all enhanced disclosures

In December 2025, the SEC also approved Nasdaq rule changes ensuring de-SPAC transactions involving OTC-traded SPACs face the same listing requirements as exchange-listed SPACs (closing a regulatory gap that some sponsors had exploited).

Why this matters: these rules dramatically raised the cost of operating a SPAC and reduced sponsors' ability to obscure unfavorable economics. The 2025 SPAC resurgence (nearly 150 new vehicles formed, more than 2023 and 2024 combined) reflects a more disciplined market--but the regulatory tightening means the easy-money era of SPAC sponsorship is over.

A Cautious SPAC Revival (Read the Fine Print)

Despite the wreckage, SPACs aren't dead. The 2025 market showed signs of maturation: close to 100 SPAC IPOs raised approximately $20.8 billion in the first three quarters, compared to 57 IPOs raising $9.7 billion in all of 2024. Serial sponsors with track records are demonstrating better post-merger performance, and redemption rates have declined 15% compared to 2024.

But the fundamental economics haven't changed. Most SPACs remain down 75% from their IPO prices. Two notable 2024 de-SPACs achieved redemption rates below 40%--but "below 40%" being noteworthy tells you everything about how bad the baseline is.

The rule that survives: a SPAC revival doesn't mean SPAC investing is safe. It means a smaller pool of better-capitalized sponsors is pursuing deals with more regulatory scrutiny. Your job as an investor is to read the S-4 filing, calculate fully diluted share count (including warrants and earnouts), and assess whether the sponsor's promote is worth the governance risk.

The Decision Framework (Which Structure Fits Which Company)

The causal chain: Company needs → Structure choice → Cost/control tradeoffs → Day 1 dynamics → Long-term shareholder outcomes

FactorFavors IPOFavors Direct ListingFavors SPAC
Capital needsRaising $100M+No capital neededModerate raise via trust + PIPE
Brand strengthModerate to lowStrong (essential)Any level
Speed priority4-6 months acceptable3-4 months3-5 months (fastest negotiation)
Market conditionsStable/bullishStableVolatile (certainty matters)
Cost tolerance6-7% acceptableMinimize cost (<1%)7-8% acceptable for speed
Insider liquidityCan wait 180 daysWant immediate liquidityVaries by agreement

Choose a traditional IPO when you need significant capital, lack consumer brand recognition, and want institutional distribution with underwriter price support. Most companies still go this route for good reason (despite the underpricing cost). In 2025, traditional IPOs still dominated: 216 deals raised $47.4 billion, dwarfing both direct listings and SPAC mergers in volume.

Choose a direct listing when you have no capital needs, a well-known brand, and employees or early investors who want immediate liquidity without dilution. The savings are enormous--but the pool of companies for which this works is small (which is why only 18 used it in seven years).

Choose a SPAC when market conditions are hostile to traditional IPOs, speed matters more than cost, and you can negotiate reduced sponsor economics. Post-2024 SEC rules mean sponsors face more accountability--which is actually a positive signal if you're evaluating a modern SPAC deal.

How to Evaluate Any Newly Public Company (Practical Filters)

Regardless of structure, newly public companies share common risks. Here's what to check:

For IPOs: Calculate the lock-up expiration date (typically 180 days post-IPO). Historical data shows average returns of -2.5% in the week surrounding lock-up expiration as insiders sell. If you're buying before that date, you're buying ahead of predictable selling pressure.

For direct listings: Compare the current price to the SEC filing's reference price. Large premiums suggest enthusiasm may have overshot. Check the first-month insider selling volume (all shares are freely tradeable from Day 1, and insiders often sell aggressively).

For SPACs: Read the S-4 filing cover to cover. Calculate the fully diluted share count (not just shares outstanding--include warrants, earnouts, and founder shares). A SPAC that looks cheap on outstanding shares can look expensive on a fully diluted basis. Check the sponsor promote percentage (anything above 20% is a red flag; anything below signals sponsor confidence).

The test: can you state the company's enterprise value on a fully diluted basis, including all SPAC-related securities? If not, you don't understand the deal well enough to invest.

Investment Checklist for Newly Public Companies (Tiered)

Essential (prevents 80% of losses)

  • Wait 30-60 days after listing before buying--let price discovery settle and initial volatility pass
  • Read the SEC filing (S-1 for IPOs/direct listings, S-4 for SPACs)--know what you're buying
  • Calculate fully diluted share count--especially for SPACs with warrants and earnouts
  • Check insider lock-up terms--know when selling pressure arrives

High-impact (systematic protection)

  • Compare Day 1 price to IPO/reference price--if you're buying 40%+ above, ask what changed
  • Track the lock-up expiration calendar--avoid buying in the two weeks before expiration
  • For SPACs, calculate sponsor promote as percentage of deal value--anything above 5% dilutes you significantly
  • Wait for the first earnings report--post-IPO volatility typically settles after companies report real numbers

Optional (for serious IPO investors)

  • Monitor redemption rates for SPAC deals--rates above 80% signal investor skepticism (and a much smaller trust)
  • Track underwriter reputation--top-tier banks (Goldman, Morgan Stanley, JPMorgan) are associated with lower post-IPO underperformance
  • Compare the company's chosen structure to its peers--unusual structure choices deserve extra scrutiny

Next Step (Put This Into Practice)

Pick one recently public company you own or are considering (from any structure). Pull its SEC filing and answer three questions:

How to do it:

  1. Go to SEC EDGAR (sec.gov/cgi-bin/browse-edgar) and search the company name
  2. Find the S-1 (IPO/direct listing) or S-4 (SPAC) filing
  3. Search the filing for "dilution," "lock-up," and "shares outstanding"

Answer these:

  • What is the fully diluted share count? (Include all warrants, options, and earnouts. Compare to "basic" shares outstanding.)
  • When does the lock-up expire? (For IPOs: typically 180 days from listing date. For SPACs: check the specific agreement.)
  • What did insiders pay vs. what you'd pay today? (SPAC sponsors often paid pennies per share for their promote. IPO insiders hold pre-IPO shares at much lower cost bases.)

Action: If the fully diluted share count is more than 15% higher than basic shares outstanding, re-evaluate your position sizing. That dilution will show up in your returns whether you account for it or not.

Related Articles